Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02149823Phase 1Terminated

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

Role: collaborator

NCT00751855Not ApplicableCompleted

Cortisol Augmentation of Prolonged Exposure Therapy

Role: lead

NCT00850447Not ApplicableCompleted

Cognitive Remediation in Posttraumatic Stress Disorder (PTSD)

Role: collaborator

All 3 trials loaded